您要查找的是不是:
- Reperfusion injurey 再灌注损伤
- Role of LAMI - 116 in Reperfusion Injury of Rat EDL. L一粘附素单抗在缺血再灌注损伤中的作用
- In reperfusion group, EAD and RA developed in 5 dogs(62.5%). 再灌注 30min内 ;单纯再灌注组 8只犬中有 5只出现了EAD和再灌注室性心律失常 ;再灌注心律失常发生率为 6 2 .;5%25 ;
- Ischemia and reperfusion did not affect the Cx43 levels. 脑缺血对缝隙连接蛋白43(Cx43)的表达无明显影响;
- Unchecked,oxygen radicals may cause reperfusion injuries and other problems. 看来,氧基能导致多次灌注的伤害和其他问题。
- CONCLUSION DK can protect myocardium against ischemia reperfusion injury. 结论dk对大鼠心肌缺血再灌注损伤有保护作用。
- Inhaled Nitric Oxide Attenuates Reperfusion Inflammatory Responses in Humans. 吸入氧化亚氮降低人类再灌注炎症反应。
- CINC not only involved in the reperfusion injury, but also acute rejection. CINC不仅参与再灌注损伤, 而且参与急性排斥反应。
- The expression of Bcl 2 and Fas protein in rat after ischemia and reperfusion. 大鼠脑缺血再灌注后Bcl-2、Fas蛋白的表达及意义
- Unchecked, oxygen radicals may cause reperfusion injuries and other problems. 看来,氧基能导致多次灌注的伤害和其他问题。
- NGF could ease the delayed neuron death (DND) after ischemia reperfusion. NGF可以减轻海马迟发性神经细胞死亡 (DND)性损伤。
- Reperfusion: Reperfusion of ischemic cells can cause further injury. 再灌注:缺血细胞再灌注可造成进一步伤害。
- Assessing the Myocardium After Attempted Reperfusion: Should We Bother? (试图再灌注后评估心肌:我们应否打扰?)
- Conclusion: Ischemia reperfusion could induce the apoptosis of the cell. 说明缺血再灌注损伤能诱发细胞凋亡。
- Myocardial reperfusion injury is a complex pathophysiological process. 心肌再灌注损伤是一个复杂的病理生理过程。
- METHODS Rats were divided into control, ischemia/ reperfusion, classic IPC and NEPC groups. 方法将实验动物分为假手术组、缺血/再灌注组、经典缺血预处理和去甲肾上腺素预处理4组。
- Objective To investigate the protective mechanism of flunarizine in gerbil brain after ischemia reperfusion. 目的进一步探讨盐酸氟桂嗪对缺血再灌注后神经细胞保护作用的机制。
- At 24h after reperfusion the intracellular calcium level reached the peak, and began to decease at 72h. 钙离子于再灌注后1h开始升高,至24h达到高峰,72h出现下降。
- The study for nuclear protein's effects on the expression of the gene coded by mitchondia after reperfusion. 核蛋白在缺血再灌注时对脑线粒体基因表达影响的研究。
- Clinical Assessment of Long Term Benefits of Reperfusion Therapies in Acute Myocardial Infarction. 急性心肌梗死患者再灌注治疗远期预后临床观察。